Biodesix (BDSX) Assets Average (2020 - 2026)

Biodesix (BDSX) has reported Assets Average for 7 consecutive years, with $91.1 million the latest figure, recorded in Q1 2026.

• Assets Average for Q1 2026 came in at $91.1 million, down 0.75% year-over-year; the trailing twelve-month figure through Mar 2026 was $91.1 million (down 0.75% YoY), and the FY2025 annual result was $92.4 million, down 5.92% from the prior year.
• Assets Average was $91.1 million for Q1 2026 at Biodesix, up from $88.1 million in the prior quarter.
• Over five years, Assets Average peaked at $109.3 million in Q3 2024 and troughed at $68.4 million in Q2 2022.
• Average Assets Average over 5 years is $86.8 million, with a median of $88.1 million recorded in 2025.
• Year-over-year, Assets Average slumped 41.77% in 2022 and jumped 32.95% in 2024.
• Over 5 years, Assets Average stood at $78.1 million in 2022, then climbed by 19.08% to $92.9 million in 2023, then gained by 7.59% to $100.0 million in 2024, then dropped by 11.9% to $88.1 million in 2025, then rose by 3.36% to $91.1 million in 2026.
• Per Business Quant data, the three most recent Assets Average figures were $91.1 million in Q1 2026, $88.1 million in Q4 2025, and $88.2 million in Q3 2025.